Likewise, we found that BCL11B expression in CD3+ T cells was significantly decreased in CLL-CD3+ T cells compared to HI-CD3+ T cells in the GSE19147 dataset (P = 0.044 Figure 3F, left panel), but RUNX3 did not demonstrate a difference between CLL and HIs (P = 0.550, Figure 3F, right panel). Here, BCL11B is linked to B-cell chronic lymphocytic leukemia.